In Africa, where malaria is usually endemic, mosquitoes of the Anopheles genus are the just vectors of the condition. The many research which have been devoted to them have led to the characterization of different species and the identification, among these, of vector species. To day, four sets of vectors of the genus Anopheles have been recorded on the African continent: Anopheles gambiae, A. Funestus, A. Nili and A. Moucheti, each comprising a couple of species, morphologically virtually identical although genetically different. They centered on the Anopheles nili group especially, with a geographical distribution that mainly addresses Central Africa. Investigations on adults and larvae collected along the banking institutions of the River Ntem, in the South of Cameroon, found proof morphological variants between specimens, making it challenging to classify them within one of the three known species of the A.Ketolide antibiotics, which represent a newer and promising course of therapeutics with greater potential against bacterial strains that are resistant to macrolides and penicillins, are typically very hard to formulate in a viable IV formulation because of low water solubility clinically. Advanced Lifestyle Sciences has achieved a significant breakthrough by effectively developing an IV formulation of Restanza. The key top features of this formulation support developing Restanza IV for make use of in the hospital setting. The next phase in this program can be to initiate extra IND-directed preclinical studies of the Restanza IV formulation to support future Phase I scientific trials in normal healthful volunteers to judge its security and pharmacokinetics..